{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:31:54Z","timestamp":1786717914384,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/ijd.ijd_71_17","type":"journal-article","created":{"date-parts":[[2017,3,8]],"date-time":"2017-03-08T08:17:23Z","timestamp":1488961043000},"page":"137","source":"Crossref","is-referenced-by-count":3,"title":["Management strategies for mycosis fungoides in India"],"prefix":"10.4103","volume":"62","author":[{"given":"Tanumay","family":"Raychaudhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0019-5154.201768-1","first-page":"1053","volume-title":"Defining early mycosis fungoides","author":"Pimpinelli","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0019-5154.201768-2","first-page":"5064","volume-title":"Cutaneous lymphoma incidence patterns in the United States: A population-based study of 3884 cases","author":"Bradford","year":"2009","journal-title":"Blood"},{"key":"key-10.4103\/0019-5154.201768-3","first-page":"436","volume-title":"Review of the treatment of mycosis fungoides and s\u00e9zary syndrome: A stage-based approach","author":"Horwitz","year":"2008","journal-title":"J Natl Compr Canc Netw"},{"key":"key-10.4103\/0019-5154.201768-4","first-page":"1014","volume-title":"EORTC consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome","author":"Trautinger","year":"2006","journal-title":"Eur J Cancer"},{"key":"key-10.4103\/0019-5154.201768-5","first-page":"ii72","volume-title":"Primary cutaneous lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up","author":"Dummer","year":"2008","journal-title":"Ann Oncol"},{"key":"key-10.4103\/0019-5154.201768-6","first-page":"2","volume-title":"Guidelines for the management of cutaneous lymphomas (2011): A consensus statement by the Japanese Skin Cancer Society \u2013 Lymphoma Study Group","author":"Sugaya","year":"2013","journal-title":"J Dermatol"},{"key":"key-10.4103\/0019-5154.201768-7","first-page":"512","volume-title":"Retrospective study of spectrum of cutaneous lymphoma presenting to dermatology","author":"Doshi","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0019-5154.201768-8","first-page":"1713","volume-title":"Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: A proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"key-10.4103\/0019-5154.201768-9","first-page":"857","volume-title":"Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: Clinical prognostic factors and risk for disease progression","author":"Kim","year":"2003","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0019-5154.201768-10","first-page":"504","volume-title":"Mycosis fungoides: Disease evolution and prognosis of 309 Dutch patients","author":"van","year":"2000","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0019-5154.201768-11","first-page":"1226","volume-title":"Prognostic factors, prognostic indices and staging in mycosis fungoides and S\u00e9zary syndrome: Where are we now?","author":"Scarisbrick","year":"2014","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0019-5154.201768-12","first-page":"3082","volume-title":"Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation","author":"Arulogun","year":"2008","journal-title":"Blood"},{"key":"key-10.4103\/0019-5154.201768-13","first-page":"123","volume-title":"Prognostic factors in cutaneous T cell lymphoma","author":"Willemze","year":"2009","journal-title":"Hematol Meet Rep"},{"key":"key-10.4103\/0019-5154.201768-14","first-page":"3766","volume-title":"Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and S\u00e9zary syndrome: Effect of specific prognostic markers on survival and development of a prognostic model","author":"Scarisbrick","year":"2015","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0019-5154.201768-15","first-page":"2859","volume-title":"A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome","author":"Benton","year":"2013","journal-title":"Eur J Cancer"},{"key":"key-10.4103\/0019-5154.201768-16","first-page":"1150","volume-title":"Transformation of mycosis fungoides\/Sezary syndrome: Clinical characteristics and prognosis","author":"Diamandidou","year":"1998","journal-title":"Blood"},{"key":"key-10.4103\/0019-5154.201768-17","first-page":"2598","volume-title":"Clinical end points and response criteria in mycosis fungoides and S\u00e9zary syndrome: A consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer","author":"Olsen","year":"2011","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0019-5154.201768-18","first-page":"1","volume-title":"Mycosis fungoides in the pediatric population: Report from an international Childhood Registry of Cutaneous Lymphoma","author":"Pope","year":"2010","journal-title":"J Cutan Med Surg"},{"key":"key-10.4103\/0019-5154.201768-19","first-page":"124","volume-title":"Phototherapy for mycosis fungoides","author":"Dogra","year":"2015","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0019-5154.201768-20","first-page":"65","volume-title":"Hypomelanoses in children","author":"van","year":"2013","journal-title":"J Cutan Aesthet Surg","ISSN":"https:\/\/id.crossref.org\/issn\/0974-2077","issn-type":"print"},{"key":"key-10.4103\/0019-5154.201768-21","first-page":"747","volume-title":"Outcome of patients treated with a single-fraction dose of palliative radiation for cutaneous T-cell lymphoma","author":"Thomas","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key-10.4103\/0019-5154.201768-22","first-page":"3142","volume-title":"How I treat mycosis fungoides and S\u00e9zary syndrome","author":"Whittaker","year":"2016","journal-title":"Blood"},{"key":"key-10.4103\/0019-5154.201768-23","first-page":"655","volume-title":"Skin directed therapy for mycosis fungoides: A review","author":"Berthelot","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"key-10.4103\/0019-5154.201768-24","first-page":"927","volume-title":"Systematic review of combination therapies for mycosis fungoides","author":"Humme","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"key-10.4103\/0019-5154.201768-25","first-page":"108","volume-title":"PUVA and cancer risk: The Swedish follow-up study","author":"Lindel\u00f6f","year":"1999","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0019-5154.201768-26","first-page":"39","volume-title":"Phototherapy for cutaneous T-cell lymphoma: Online survey and literature review","author":"Carter","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0019-5154.201768-27","first-page":"354","volume-title":"PUVA plus interferon \u03b12b in the treatment of advanced or refractory to PUVA early stage mycosis fungoides: A case series","author":"Nikolaou","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0019-5154.201768-28","first-page":"678","volume-title":"Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: Final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056)","author":"Whittaker","year":"2012","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0019-5154.201768-29","first-page":"247","volume-title":"Acitretin for the treatment of cutaneous T-cell lymphoma","author":"Cheeley","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0019-5154.201768-30","first-page":"247","volume-title":"Treatment of cutaneous T cell lymphoma with a combination of low-dose interferon alfa-2b and retinoids","author":"Knobler","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0019-5154.201768-31","first-page":"873","volume-title":"Low-dose methotrexate to treat mycosis fungoides: A retrospective study in 69 patients","author":"Zackheim","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0019-5154.201768-32","first-page":"836","volume-title":"Interferon and low dose methotrexate improve outcome in refractory mycosis fungoides\/S\u00e9zary syndrome","author":"Avil\u00e9s","year":"2007","journal-title":"Cancer Biother Radiopharm"},{"key":"key-10.4103\/0019-5154.201768-33","first-page":"286","volume-title":"Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: Results of a pooled analysis from 3 phase-II clinical trials","author":"Hoppe","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0019-5154.201768-34","first-page":"720","volume-title":"Long-term efficacy and safety of alemtuzumab in advanced primary cutaneous T-cell lymphomas","author":"de","year":"2014","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0019-5154.201768-35","first-page":"171","volume-title":"Mogamulizumab for the treatment of cutaneous T-cell lymphoma: Recent advances and clinical potential","author":"Duvic","year":"2016","journal-title":"Ther Adv Hematol"},{"key":"key-10.4103\/0019-5154.201768-36","first-page":"71","volume-title":"Lack of durable disease control with chemotherapy for mycosis fungoides and S\u00e9zary syndrome: A comparative study of systemic therapy","author":"Hughes","year":"2015","journal-title":"Blood"},{"key":"key-10.4103\/0019-5154.201768-37","first-page":"111","volume-title":"Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides: Evidence of a graft-versus-tumor effect","author":"Burt","year":"2000","journal-title":"Bone Marrow Transplant"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:29:11Z","timestamp":1786714151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.IJD_71_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"alternative-id":["201768"],"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_71_17","relation":{},"ISSN":["0019-5154"],"issn-type":[{"value":"0019-5154","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}